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Abstract
Background: The primary objective of this study is to estimate the association between body
mass index (BMI) and the risk of first acute myocardial infarction (AMI). As a secondary objective,
we considered the association between other lifestyle variables, smoking and heavy alcohol use,
and AMI risk.
Methods: This study was conducted in the general practice research database (GPRD) which is a
database based on general practitioner records and is a representative sample of the United
Kingdom population. We matched cases of first AMI as identified by diagnostic codes with up to
10 controls between January 1st, 2001 and December 31st, 2005 using incidence density sampling.
We used multiple imputation to account for missing data.
Results: We identified 19,353 cases of first AMI which were matched on index date, GPRD
practice and age to 192,821 controls. There was a modest amount of missing data in the database,
and the patients with missing data had different risks than those with recorded values. We adjusted
our analysis for each lifestyle variable jointly and also for age, sex, and number of hospitalizations
in the past year. Although a record of underweight (BMI <18.0 kg/m2) did not alter the risk for AMI
(adjusted odds ratio (OR): 1.00; 95% confidence interval (CI): 0.87–1.11) when compared with
normal BMI (18.0–24.9 kg/m2), obesity (BMI ≥30 kg/m2) predicted an increased risk (adjusted OR:
1.41; 95% CI: 1.35–1.47). A history of smoking also predicted an increased risk of AMI (adjusted
OR: 1.81; 95% CI: 1.75–1.87) as did heavy alcohol use (adjusted OR: 1.15; 95% CI: 1.06–1.26).
Conclusion: This study illustrates that obesity, smoking and heavy alcohol use, as recorded during
routine care by a general practitioner, are important predictors of an increased risk of a first AMI.
In contrast, low BMI does not increase the risk of a first AMI.
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Background
Obesity is a growing public health problem that is associ-
ated with an increased rate of cardiovascular events.
About one in three patients admitted to hospital with
acute coronary syndrome in Europe were obese with addi-
tionally half of the patient population being overweight
[1].
Clinical databases based on general practice records are a
potentially useful source of information (when it is avail-
able) for studying the magnitude of risk factors such as
obesity, smoking and heavy alcohol use at the population
level in a real-world setting. However, these databases
often have missing data on some patients which needs to
be properly accounted for in any analysis. Several meth-
ods exist [2,3], but multiple imputation has been system-
atically shown to be superior to case deletion and
indicator variable methods in reducing bias [4-6].
As obesity is a growing public health concern, it is impor-
tant to identify the impact of body mass index (BMI) in
the occurrence of the first acute myocardial infarction
(AMI). The primary objective of this study is to estimate
the association between BMI and the risk of the first AMI.
As a secondary objective, we considered the association
between other lifestyle variables, smoking and heavy alco-
hol use, and AMI risk. Finally, we sought to determine if
the choice of how to deal with missing information was
important.
Methods
Study population
This study is based on the United Kingdom's General
Practice Research Database (GPRD) [7]. This is a large
clinical database based on the medical charts of general
practitioners. It records information such as prescriptions
issued and medical diagnoses made using the United
Kingdom specific READ and OXMIS medical codes. The
recorded information on drug exposure and diagnoses
has been validated and proven to be of high quality [7,8].
The GPRD also records information on factors such as
BMI, blood pressure, smoking and alcohol consumption
[7]. However, these variables are reported by validation
studies to have non-trivial amounts of missing data [7,8]
and this can lead to biased estimates of effect [9].
We identified all first-ever AMIs recorded in the GPRD
between January 1st, 2001 and December 31st, 2005 using
the medical codes recorded in the database as our cases.
These medical codes are described in Additional File 1. To
be eligible to be selected as a case, a patient needed to be
at least 18 years of age and have no previous record of an
AMI before the index event. The date recorded in the data-
base for the first AMI was taken as the index date for the
case. We matched each case with up to 10 controls based
on age (± 2 years), GPRD practice and index date. On the
index date, the control must not have had a previous AMI,
must still be registered in the GPRD and be alive to be eli-
gible as a control.
Both cases and controls were required to have at least 3
years of follow-up in the GPRD before the index date to
allow adequate time to assess comorbid conditions.
BMI was defined as the most recently available pre-AMI
body weight (in kilograms) divided by the square of the
height (in meters) (kg/m2) and was used to categorize
patients according to the World Health Organization's
definition [10]: underweight (BMI: <18.0 kg/m2), normal
weight (BMI: 18.0–24.9 kg/m2), overweight (BMI: 25–
29.9 kg/m2) and obese (BMI: ≥30 kg/m2).
For smoking we grouped subjects into the categories of
never smokers and ever smokers. For heavy alcohol use we
used at least one clinical diagnosis recorded in the data-
base. For BMI and smoking status, we used the closer to
the index date recorded value in the database. However,
for most patients BMI and smoking status are recorded
only once in the GPRD [7].
Ethical review for this study was done by the Independent
Scientific Advisory Committee for MHRA database
research
Statistical Analysis
Conditional logistic regression was used to estimate the
odds ratios (ORs) for the different BMI categories. We
handled missing data using three different typical
approaches (case deletion, indicator variable and multi-
ple imputation). It was important to include a broad spec-
trum of covariates as predictors in our multiple
imputation model [11,12]. We considered a crude model
for BMI, smoking and heavy alcohol use, separately.
Because of the cross-sectional nature of our data, we could
not assess whether comorbidities preceded obesity, and so
we did not adjust for these variables in our statistical mod-
els (although they were used in the multiple imputation
to infer BMI). Instead, we limited our statistical adjust-
ment to each lifestyle variable jointly, as well as age, sex
and number of hospitalizations in the past year (as a
proxy for overall health status).
More details of the imputation and analysis are discussed
in Additional File 2.
Results
We identified 19,353 cases of AMI which were matched to
192,821 controls. Selected characteristics of the cases and
the controls are described in Table 1. The pattern of miss-
ing data in this study is also shown in Table 1 as are theBMC Cardiovascular Disorders 2007, 7:38 http://www.biomedcentral.com/1471-2261/7/38
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post-imputation results of some variables. The cases have
higher rates and levels of known cardiovascular risk fac-
tors including diabetes and angina as well as elevated
blood pressure and serum cholesterol levels.
Table 2 describes the distribution of BMI and smoking
among subjects with imputed values for BMI as opposed
to subjects with measured BMI. Of note is that the size of
the underweight category is much greater among those
subjects with imputed BMIs; it is 1.8% versus 3.8% in the
cases and 1.8% versus 4.7% in the controls. In general,
patients with imputed values have systematically lower
rates of smoking and lower BMI values than subjects with
recorded information.
Table 3 describes the relationship between BMI and the
rate of AMI. A pronounced increased risk in the obese
patients was found regardless of how we account for miss-
ing data. Using the adjusted estimates from the multiple
imputation analysis, there is an increase in risk in the
obese (adjusted OR: 1.41; 95% confidence interval (CI):
1.35–1.47). The change in adjusted OR for the under-
weight, as based on different methods of handling miss-
ing data, was the most important with a 15.3% change in
the estimate between case deletion (adjusted OR: 1.15;
Table 1: Lifestyle information and percentage of missing data in subjects comparing patients acute myocardial infarction (cases) to the 
general population from which cases arose (controls).
Basic Descriptive Statistics Cases (n = 19,353) Controls (n = 192,821)
Mean age (SD) 70.0 (13.1) 69.9 (13.0)
Male 54.4% 44.1%
% heavy alcohol use 3.6% 2.3%
# hospitalizations/past year (SD) 0.33 (1.14) 0.16 (0.81)
Variables Rates of missing values (%)
Smoking 8.4 12.3
Body Mass Index 20.6 23.5
Blood Pressure 30.6 43.6
Estimated Systolic Blood Pressure (SD) 144.1 (18.7) 142.2 (17.7)
Estimated Diastolic Blood Pressure (SD) 81.0 (10.1) 80.4 (9.0)
Serum Cholesterol 64.4 76.2
Estimated Serum Cholesterol (SD) 5.54 (1.16) 5.49 (1.20)
Key Comorbidities
Diabetes 15.8% 9.1%
Angina 20.2% 11.8%
Renal Failure 3.0% 1.1%
Chronic Obstructive Pulmonary Disease 8.2% 5.1%
Stroke 5.5% 3.5%
* SD: standard deviation.
Table 2: Comparison of distributions of body mass index and smoking among subjects with measured body mass index values and 
those with imputed body mass index values.
Cases Controls
Measured (N = 15,423) Imputed (N = 3,930) Measured (N = 146,725) Imputed (N = 46,096)
Body Mass Index
<18.0 1.8% 3.8% 1.7% 4.7%
18.0–24.9 35.2% 35.6% 40.9% 39.9%
25.0–29.9 40.8% 40.7% 39.0% 38.6%
≥30.0 22.1% 19.9% 18.3% 16.8%
Mean (SD) 26.8 (4.8) 26.2 (4.6) 26.3 (4.7) 25.6 (4.6)
Smoking
Ever 56.9% 53.6% 40.9% 40.0%
Never 43.1% 46.7% 59.0% 60.0%
SD: standard deviation.BMC Cardiovascular Disorders 2007, 7:38 http://www.biomedcentral.com/1471-2261/7/38
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95% CI: 0.96–1.37) and multiple imputation (adjusted
OR: 1.00; 95% CI: 0.87–1.11).
Table 4 describes the results for ever smoker versus never
smoker using the three different approaches for missing
values. In this population sample we confirm the well-
known finding that ever smoking is a strong risk factor for
having an AMI (adjusted OR: 1.81; 95% CI: 1.75–1.87).
This effect was consistently shown with all three different
methods used to account for missing values.
Furthermore, subjects with a clinical diagnosis of heavy
alcohol use appeared to have a small increased risk of a
first AMI (adjusted OR: 1.15; 95% CI: 1.06–1.26).
Discussion
This is the first study evaluating the association between
BMI and the first AMI, using a clinical database based on
general practitioner records (GPRD). It is a case-control
study that includes a large sample of consecutive, unse-
lected cases with AMI and matched controls. Therefore, it
reflects real life data including a large proportion of
female and elderly patients. In this study we also assessed
the impact of smoking and heavy alcohol use on the
occurrence of the first AMI. We used three different meth-
ods to account for missing data, namely case deletion,
indicator variable and the more sophisticated multiple
imputation method.
BMI as a risk factor
In our study, we observe that low and normal BMI values
are not associated with an increased risk of a first AMI but
that high BMI values are. This shape could be described as
a J-shaped association between BMI categories in which
we have no effect on one direction from normal and an
increased risk in the other. To our knowledge, this is the
Table 3: Relationship between body mass index and acute myocardial infarction using three different methods to account for missing 
values (odds ratio, 95% confidence interval). The normal BMI category (18.0–24.9 kg/m2) was used as the reference group.
Body mass index (kg/m2) Case Deletion Indicator Variable Multiple Imputation (10 copies)
Crude Estimates of Effect
<18.0 1.23 (1.03–1.46) 1.21 (1.02–1.44) 1.03 (0.91–1.17)
18.0–24.9 Reference Reference Reference
25.0–29.9 1.21 (1.15–1.27) 1.21 (1.15–1.27) 1.20 (1.16–1.24)
≥30.0 1.35 (1.27–1.43) 1.35 (1.27–1.43) 1.40 (1.34–1.46)
Missing Indicator n/a 0.96 (0.91–1.02) n/a
Adjusted* Estimates of Effect
<18.0 1.15 (0.96–1.37) 1.13 (0.95–1.35) 1.00 (0.87–1.11)
18.0–24.9 Reference Reference Reference
25.0–29.9 1.18 (1.12–1.24) 1.18 (1.12–1.24) 1.16 (1.14–1.21)
≥30.0 1.35 (1.27–1.44) 1.35 (1.27–1.44) 1.41 (1.35–1.47)
Missing Indicator n/a 1.13 (1.06–1.20) n/a
n/a: not applicable.
* matched for age, GPRD practice and index date and adjusted for age, sex, heavy alcohol use, smoking and number of hospitalizations in the past 
year.
Table 4: Relationship between smoking status and acute myocardial infarction as shown using three different methods to account for 
missing values and analyzed using conditional logistic regression (odds ratio, 95% confidence interval). The never smoking group was 
used as the reference.
Smoking status Case Deletion Indicator Variable Multiple Imputation (10 copies)
Crude Estimates of Effect
Ever 1.92 (1.84–2.00) 1.92 (1.84–2.00) 1.90 (1.84–1.97)
Never Reference Reference Reference
Missing n/a 0.88 (0.82–0.95) n/a
Adjusted* Estimates of Effect
Ever 1.83 (1.75–1.91) 1.83 (1.75–1.91) 1.81 (1.75–1.87)
Never Reference Reference Reference
Missing n/a 0.86 (0.79–0.94) n/a
n/a: not applicable.
* matched for age, GPRD practice and index date and adjusted for age, sex, heavy alcohol use, smoking and number of hospitalizations in the past 
year.BMC Cardiovascular Disorders 2007, 7:38 http://www.biomedcentral.com/1471-2261/7/38
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first study to describe this effect for first AMI in a United
Kingdom population sample.
Despite previous research, controversy remains regarding
the relationship between BMI and AMI [13-16]. Some
studies have shown that BMI has a U-shaped effect (bimo-
dal occurrence) of adverse events and adverse outcomes
with an increased risk in underweight and morbidly obese
people, but with a lower risk for overweight and obese
when compared to normal-weight patients. However,
these studies have often not comprehensively accounted
for potential sources of confounding, with underestimates
of the effect of overweight and obesity on longevity and
overestimates of the risks of leanness. Major potential
sources of bias particular to studies of BMI and mortality
include (1) failure to adequately account for missing val-
ues, (2) failure to adequately account for potential sources
of confounding (e.g. pre-existing disease or concomitant
illnesses such as cancer, leukemia and lymphoma), (3)
unmeasured factors that affected outcomes, and (4) inap-
propriate adjustment for the biological effects of obesity
(i.e. for conditions that included in the causal pathway
between obesity and AMI), including hypertension and
diabetes. Also some prior studies are not very informative
as they are hospital-based and they focus on the outcome
after AMI. Furthermore, a study of AMI patients followed
for 8–10 years showed that although overall obesity (as
assessed by BMI) is inversely related to mortality, abdom-
inal obesity appears to be an independent predictor of all-
cause mortality in men and perhaps also in women [17].
Other studies have found similar results with ours but
mostly for mortality. In the Multifactor Primary Preven-
tion Study, when the BMI category 20.0–22.5 kg/m2 was
used as the reference group, the underweight group did
not carry a higher risk for an AMI (adjusted Hazard Ratio
(HR): 1.08; 95% CI: 0.76–1.52) or for coronary artery
bypass graft without prior AMI (adjusted HR: 0.86; 95%
CI: 0.25–2.90). However, overweight and obese patients
were carrying a higher risk for AMI when compared with
the normal BMI category [18].
In a prospective study of more than 1,000,000 adults in
the United States the curve for the risk of death from car-
diovascular disease among subjects who never smoked
and had no history of disease was J-shaped; this indicated
that a high BMI was most predictive of death from cardio-
vascular disease than a low BMI. However, the curve for
the risk of death from all other causes was U-shaped [19].
A recent meta-analysis including 302,296 participants
worldwide and 18,000 coronary heart disease events dur-
ing follow-up showed that there was an increased risk for
coronary events associated with overweight and obesity;
the adjusted relative risk (and 95% CI) was 1.32 (1.24–
1.40) for BMI of 25.0 to 29.9 kg/m2 and 1.81 (1.56–2.10)
for BMI ≥30 kg/m2, when compared with normal BMI
[20].
Smoking and heavy alcohol use as risk factors
An increased risk of a first AMI was associated with ever
smoking. This finding was consistently found regardless
of the method used to deal with missing values. This
strong association between smoking and AMI has been
shown before. For example, the INTERHEART study
found that tobacco use is one of the most important
causes of AMI globally, especially in men. The risk for AMI
was increased regardless of the form of tobacco use,
including different types of smoking and chewing tobacco
and inhalation of second hand tobacco smoke [21].
Another study also found that the type or yield of ciga-
rettes did not result in significantly different findings, with
similar risk for smoker of low versus high tar cigarettes
[22].
Heavy alcohol use was also consistently associated with a
higher risk of a first AMI in our study. Heavy alcohol use
is a known risk factor for cardiovascular risk. The INTER-
HEART study, among others, also found this association
[23].
Missing data
We used three common methods to deal with missing
data. In cases where there is a difference between the
results of the case deletion, indicator variable and multi-
ple imputation, simulation studies have demonstrated the
superiority of multiple imputation method when missing
data exceed 10% of the total [6]. In our study, only smok-
ing met that criterion <10% missing among cases and
only slightly more among controls. In all methods, smok-
ing was a strong risk factor for AMI, with little to no
change in estimate as we accounted for missing data with
different methods.
The pattern of obesity by measured versus unmeasured
BMI (as shown in Table 2) demonstrates the circum-
stances under which multiple imputation will make a dif-
ference in the results of a study. The only category of
weight shows important differences in the estimates of the
effect of BMI on AMI between those with a measure of
BMI and those without one is the underweight. In the
underweight we found a 15.3% difference in the estimates
of the risk of AMI between using case deletion versus mul-
tiple imputations to handle missing data. While we are
fortunate in this case not to have this bias shift the infer-
ence (as neither is statistically significant), this is not guar-
anteed in future studies. In such cases, the estimate from
multiple imputation should be preferred [4-6,12].BMC Cardiovascular Disorders 2007, 7:38 http://www.biomedcentral.com/1471-2261/7/38
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Strengths and limitations
This is a broad and unselected population sample of the
United Kingdom population that allows us to infer the
current levels of risk. Due to the comprehensive nature of
the covariates in the database, we were able to use an
extremely rich wealth of information in imputing missing
data. This allows us to describe the empirical risk associ-
ated with different levels of BMI as seen by general practi-
tioners. Recently, the INTERHEART study also reported
that, among others, smoking, obesity, bad dietary habits
and alcohol intake, as well as lack of regular physical
activity account for most of the risk of AMI worldwide in
both sexes and at all ages in all regions [23].
However, this study also has several limitations. We
defined the "first AMI" as the first event occurred after at
least 3 consecutive years of being followed in the GPRD
and being free of an AMI. This might also include some
patients who had their AMI after long intervals. However,
as there is very good validation for hospital referrals (and
communication with specialists) [7], it is very uncommon
if a patient with a previous MI was not followed by a Car-
diologist/Specialist and/or did not have any follow-up
tests for at least 3 years. Also in general, in database stud-
ies collection of data is often less standardized or less
accurate; however, GPRD is a popular database and many
validation studies have proven satisfactory accuracy and
completeness of the data [7]. Despite adjustments using
multivariate analyses, unmeasured factors that affected
outcomes were likely present. The BMI was used as a
marker for total body fat, while the distribution of body
fat is unknown. However, there is evidence supporting
that there is a good correlation between BMI and central
obesity, a known risk factor for cardiovascular events [24].
We treated smoking as a binary variable. This approach
has been known to be subject to misclassification [25] in
the GPRD. However, we avoided classifying the patients
as never, current and ex smokers as the GPRD does not
systematically track quitting and starting patterns among
smokers. Also there is no information on the duration,
intensity or type of smoking available in the GPRD. The
same limitation applies for the clinical diagnosis of heavy
alcohol use. We do not have information on the severity
of AMI; it was shown that different levels of healthy life-
style are associated with the severity of cardiac events and
outcomes after the event [26].
Furthermore, we are not able to verify the assumption that
the missing data were ignorable (an assumption of multi-
ple imputation in that the missing data can be completely
predicted from the observed data) [4-6,12]. It is possible
that more information would be required to generate an
unbiased prediction of the data than is present in this
database and this cannot be tested without this data.
However, it is quite plausible that the nature of data col-
lection in the GPRD will be such that the data is not miss-
ing at random and so the estimates of missing BMI values
should be interpreted with caution.
The estimates of effect found in this paper are not pro-
tected against misclassification of the exposure. Also, the
temporal sequence of variables that are measured cross-
sectionally (like BMI) in the GPRD cannot be captured. As
can be seen in Figure 1, the analysis of these variables
requires assumptions about whether the covariate is a
common cause of the exposure and the outcome (and
thus a confounder) [27,28] or if it lies in the causal path-
way between the exposure and the outcome (and should
not be adjusted for). Our study makes the assumption, as
has been seen in other contexts [27], that the estimate
adjusted only for age and sex is the correct model given
our understanding of the relationships between the candi-
date confounders and the exposure. Future researchers,
however, can and should test these conceptual models
with longitudinal data.
Conclusion
Future work in this area in the GPRD should account for
the properties of the missing data in this database. How-
ever, once the missing data are properly accounted for, the
Directed Acyclic Graphs (DAGs) showing the difference  between a) a confounding variable and b) a variable on the  causal pathway Figure 1
Directed Acyclic Graphs (DAGs) showing the difference 
between a) a confounding variable and b) a variable on the 
causal pathway. Here the example of body mass index (BMI) 
(exposure), acute myocardial infarction (AMI) (outcome) and 
diabetes (covariate) is used. The statistical approaches in this 
paper assume case b) for the comorbid conditions listed in 
table 1.
BMI 
Diabetes 
AMI 
a) 
BMI 
Diabetes 
AMI 
b) BMC Cardiovascular Disorders 2007, 7:38 http://www.biomedcentral.com/1471-2261/7/38
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GPRD appears to be a rich source of data on lifestyle risk
factors at the population level. The interesting finding of
a J-shaped relationship between BMI and risk of first AMI,
while seen for mortality in previous work, is novel for first
AMI and should be explored further.
This work on obesity can be extended to other areas where
the relationship between obesity and the disease is less
well-known [29]. Meanwhile, physicians should continue
to advise patients to try and modify lifestyle factors, where
possible, to reduce AMI risk.
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